Tech Company Financing Transactions

elbion NV Funding Round

3i Venture Capital and Burrill & Company participated in a $31.8 million Series A funding round for elbion NV. The funding round was recorded on 1/10/2005.

Transaction Overview

Company Information

Company Status

Out of Business

Industry

Biopharmaceutical

Mailing Address

Halvestraat 3
Leuven, 3000
Belgium

Phone

+32-16-855000

Website

www.elbion.com

Email Address

[email protected]

Overview

elbion discovers and develops new small molecule drugs. Inflammatory and central nervous system diseases with high unmet medical need and high commercial potential are at the center of elbion's project pipeline, which covers all stages from early hits to advanced clinical projects.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Bernd Kastler

        

Browse more venture capital transactions:

Prev: 1/6/2005: Tejas Networks venture capital transaction
Next: 1/10/2005: Netezza venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary